Teleflex (TFX) has quietly become a talking point after another choppy week for medtech names, with the stock drifting lower over the past week even as the past month’s performance turned positive.

Montagu and Kohlberg will acquire Teleflex Medical OEM for $1.5B in a carve-out deal, closing in 2026. Private equity firms Montagu and Kohlberg have announced plans to acquire Wayne, PA-based OEM ...

Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...

Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the ...

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the company’s Acute Care, Interventional Urology ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two ...

Medical device maker Teleflex said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its ...

The OEM arm is sold to private equity firms Montagu and Kohlberg, while UK-based Intersurgical will take over the other two ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...

Teleflex said it plans to sell three of its businesses for a total of $2.03 billion in cash as it continues to focus on its core markets.

Teleflex Incorporated announced it has entered into definitive agreements to sell the company’s acute care, interventiona ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...